MG
EYPT icon

Michael Gelband’s EyePoint Inc EYPT Stock Holding History

Michael Gelband’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-458,102
Closed -$5.9M – 1714
2026
Q1 		$5.9M Sell
458,102
-85,975
-16% -$1.29M 0.05% 388
2025
Q4 		$9.94M Buy
+544,077
New +$7.71M 0.08% 262
2024
Q4 		– Sell
-11,468
Closed -$92K – 1671
2024
Q3 		$92K Buy
+11,468
New +$101K ﹤0.01% 1514
2022
Q1 		– Sell
-10,932
Closed -$134K – 2324
2021
Q4 		$134K Buy
+10,932
New +$147K ﹤0.01% 1903
2021
Q3 		– Sell
-13,400
Closed -$120K – 2260
2021
Q2 		$120K Sell
13,400
-39,156
-75% -$376K ﹤0.01% 2110
2021
Q1 		$534K Buy
+52,556
New +$591K 0.01% 1297
2019
Q2 		– Sell
-15,938
Closed -$285K – 1176
2019
Q1 		$285K Buy
15,938
+9,909
+164% +$235K 0.02% 482
2018
Q4 		$114K Buy
+6,029
New +$146K 0.01% 304

Other funds holding EYPT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Michael Gelband's EYPT Position: Q2 2026 in Review

Michael Gelband sold out of EyePoint Inc (EYPT) in Q2 2026, closing a stake of 458,102 shares — an estimated $5.9M sold.

Michael Gelband first reported a position in EYPT in Q4 2018 and held it in 8 quarters. The position peaked at $9.94M in Q4 2025. 187 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

  • Michael Gelband reported no remaining EyePoint Inc position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 458,102 EyePoint Inc shares in Q2 2026, an estimated $5.9M.
  • Michael Gelband first reported a position in EyePoint Inc in Q4 2018 and held it in 8 quarters.
  • Michael Gelband's EyePoint Inc position peaked at $9.94M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.